Riskpilot← Back to searchSign inGet full accessMediteq Svenkebo AB
ABActiveOrg 5569497638Kämpegatan 6Business and other management consultancy activities · NACE 7020Est. 20138 employees
Revenue 2025
SEK 11,5M
+12% vs 2024
EBITDA margin
4.0%
-67% vs 2024
Equity ratio
44.5%
Financial strength
Net profit 2025
SEK 478K
-47% vs 2024
| Revenue | SEK 11,5M | +12% |
| EBITDA | SEK 465K | -67% |
| Net profit | SEK 478K | -47% |
| Total assets | SEK 6,4M | -4% |
| Equity | SEK 2,9M | +5% |
| Employees | 8 | — |
Legal name
Mediteq Svenkebo AB
Org number
5569497638
Legal form
Aktiebolag
NACE code
7020 · Business and other management consultancy activities
Founded
21 november 2013
Share capital
SEK 50 000
Employees
8 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Firman tecknas var för sig av ledamoten suppleanten
Company purpose
Aktiebolaget ska bedriva konsulttjänster samt utbildning inom kvalitet, regulatory affairs och produktutveckling för branscherna medicinteknik och IT, samt liknande verksamhet.
Address
Kämpegatan 6
Phone
+46317742500
Email
helen@mediteq.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 12 798 | 8 347 | 7 816 | 10 258 | 11 501 |
| Staff expenses | — | −6 603 | — | −7 013 | −8 101 |
| EBITDA | 1 246 | 93 | −66 | 1 399 | 465 |
| Depreciation & amort. | −60 | −88 | −63 | −49 | −25 |
| EBIT | 1 186 | 6 | −129 | 1 350 | 441 |
| Net financials | — | 1 | 27 | 32 | 25 |
| Profit before tax | 985 | 7 | 28 | 1 152 | 616 |
| Tax | −210 | −7 | −13 | −252 | −137 |
| Net profit | 775 | −0 | 15 | 900 | 478 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 6 267 | 4 590 | 4 429 | 6 662 | 6 427 |
| Equity | 2 589 | 2 299 | 2 064 | 2 714 | 2 863 |
| Long-term debt | 0 | — | 0 | — | — |
| Short-term debt | 2 678 | 1 291 | 1 495 | 2 848 | 2 615 |
| Total debt | 2 678 | 1 291 | 1 495 | 2 848 | 2 615 |
EBITDA margin
4.0%
This company
15.8%
Market median
-75% vs market
20212025
Equity ratio
44.5%
This company
38.2%
Market median
+16% vs market
20212025
Return on equity
16.7%
This company
18.4%
Market median
+9% vs market
20212025
Net profit margin
4.2%
This company
8.1%
Market median
-48% vs market
20212025
Asset turnover
1.79×
This company
1.12×
Market median
+60% vs market
20212025
Debt / equity
1.25×
This company
0.62×
Market median
-102% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
MH Chief Executive Officer | Chief Executive Officer | 2022 |
AG Chief Auditor | Chief Auditor | 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Deputy Board Member | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Mediteq Svenkebo AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Maria Helén Sandelin | Chief Executive Officer | 0 companies |
| Anders Gunnar Blohmé | Chief Auditor | 0 companies |
| Mats Åke Sandelin | Deputy Board Member | 0 companies |